Figure 2 Projected Total Costs During Bridging Period LOWER COSTS ASSOCIATED WITH HOME DISCHARGE OF...
-
Upload
paige-foley -
Category
Documents
-
view
214 -
download
1
Transcript of Figure 2 Projected Total Costs During Bridging Period LOWER COSTS ASSOCIATED WITH HOME DISCHARGE OF...
$0
$50,000
$100,000
$150,000
$200,000
$250,000
$300,000
0 25 50 75 100 125 150
Day
$0
$20,000
$40,000
$60,000
$80,000
$100,000
0 10 20 30 40 50
Day
Figure 2Projected Total Costs During Bridging Period
LOWER COSTS ASSOCIATED WITH HOME DISCHARGE OFBRIDGE-TO-TRANSPLANT PATIENTS USING THE TLC-II
PORTABLE DRIVERBACKGROUNDApproximately 2,400 patients receive heart transplants each year. Of those 2,400 patients, about 15 to 20 percent are first implanted with a ventricular assist device (VAD) while awaiting a donor heart. In November 2003, the TLC-II Portable Driver received FDA approval for home use in support of bridge-to-transplant (BTT) patients implanted with the Thoratec VAD System. Before the availability of the TLC-II Portable Driver, patients were confined to an inpatient stay while awaiting heart transplantation, averaging 108 days as previously determined by DeRose1 et al.
VADImplantation
Continued Hospital Inpatient
Stay
Discharge to Home
TLC-IIPurchase
TLC-IIRental
HeartTransplantation
Our objective was to compare the medical costs incurred during home discharge supported by a TLC-II Portable Driver versus continued hospital inpatient stay, which is the current standard of care for a BTT patient.
METHODSIn order to design a model to project medical costs during the bridging period for a BTT, a literature review was undertaken. The following were determined, based on data from the study by Morales2 et al, on the associated cost of VADs, the Thoratec equipment price listing, and industry experience:
Estimated inpatient cost per day
Estimated home discharge cost per day
Hospital acquisition cost for two TLC-II Portable Drivers as required for FDA compliance
Estimated TLC-II Portable Driver rental cost per month
The model was setup using a spreadsheet to calculate the costs associated with a continued hospital inpatient stay, discharge home with the purchase of two TLC-II Portable Drivers, and discharge home with the rental of two TLC-II Portable Drivers over a range of 0 to 150 days.
Equations for each cost scenario:
Continued hospital inpatient stay: [Cost = Inpatient Cost per Day x Days]
Discharge home with purchase of two TLC-II Portable Drivers: [Cost = (Home discharge cost per day x Days) + TLC-II acquisition cost]
Discharge home with rental of two TLC-II Portable Drivers: [Cost = (Home discharge cost per day x Days) + TLC-II rental cost per month]
Scatter line graphs were plotted using the equations to compare:
The cost of continued inpatient stay vs. home discharge with purchase of the TLC-II Portable Driver
The cost of continued inpatient stay vs. home discharge with rental of the TLC-II Portable Driver
From the literature review, it was determined that the costs during the bridging period for continued inpatient stay were made up of general floor, medication, laboratory tests, dressing supplies, and professional fees. The daily costs for these components were $1,604, $3, $10, $5, and $50 respectively. The estimated daily inpatient cost was determined to be $1,672 per day.
Table 1Medical Costs Associated with TLC-II Driver
ExpensesContinuous
Hospital Stay
Discharge Home w/
TLC-II Purchase
Discharge Home w/
TLC-II Rental
General Floor $1,604 $0 $0
Medication $3 $3 $3
Laboratory Tests
$10 $10 $10
Dressing Supplies
$5 $5 $5
Professional Fees
$50 $7 $7
Medical Costs $1,672 $25 $25
For patients discharged home, the daily medical costs for medication, laboratory tests, and dressing supplies are the same as in the hospital inpatient setting. However, general floor costs are eliminated and professional fees are reduced to $7 per day. The estimated daily cost for home discharge was determined to be $25 per day.
Table 2Summation of Costs Associated with TLC-II Driver
ExpensesContinuous
Hospital Stay
Discharge Home w/
TLC-II Purchase
Discharge Home w/
TLC-II Rental
Medical Cost $1,672/day $25/day $25/day
Cost of TLC-II $0 $150,000 $12,500/month
Home discharge with the purchase ($150,000) or rental ($12,500) of the TLC-II Portable Driver observed much higher initial cost than the cost of a hospital inpatient stay. However, as the cost points were projected over time, the cost of the hospital inpatient stay climbed much more rapidly than the cost of home discharge.
$0
$30,000
$60,000
$90,000
$120,000
$150,000
$180,000
Day 1 Day 50 Day 100
Inpatient Purchase Rental
RESULTS
OBJECTIVES
The cost of continued hospital inpatient stay equaled the cost of home discharge after 91.1 ($152,280) and 7.6 ($12,690) days of bridging for the TLC-II Portable Driver purchase and rental scenario respectively. The cost of a hospital inpatient stay for bridging days greater than 91.1 in a purchase scenario and 7.6 in a rental scenario, rose much faster than cost of home discharge.
91.1 days
BTT w/o discharge
BTT w/ discharge (purchase)
Figure 1Bridge-to-Transplant Patient Path
Figure 3Inpatient vs. Home Discharge Costs Assuming TLC-II Purchase
7.6 days
BTT w/o discharge
BTT w/ discharge (rental)
Figure 4Inpatient vs. Home Discharge Costs Assuming TLC-II Rental
CONCLUSIONSHome discharge with the TLC-II Portable Driver may incur lower costs than continued outpatient hospitalization if the bridging period is in a purchasing scenario over three months or if the bridging period is in a rental scenario over one week, both of which are within the typical bridging time frame.
REFERENCES1. DeRose JJ, Umana JP, Argenziano M, et al. “Implantable left ventricular assist device provide an excellent outpatient bridge to transplant and recovery.” J Am Coll Cardiol 1997;30:1773-1777.
2. Morales DL, Catanese KA, Williams MR, et al. “Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary.” J Thorac Cardiovasc Surg 2000;119:251-9.
Research supported by Thoratec Corporation
"Being able to go home lifted my spirits. I had more freedom and felt that I could get back to recovering at my own pace. I don't think I'd be here today without that experience.“- Joe Mazurek, TLC-II Patient
The compact 9.8 kg Thoratec TLC-II Portable Driver provides
univentricular or biventricular support for short- to long-term use.